Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Propranolol for the Post-Stroke Pneumonia

NCT05419193 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT05419193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05419193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Propranolol for the Post-Stroke Pneumonia
Lead sponsor
Beijing Tiantan Hospital
Phase
Phase 2/3
Overall status
Completed
Start date
February 21, 2023
Completion date
March 11, 2025
Enrollment
168 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhagic stroke, intracerebral hemorrhage, intracranial hemorrhages, stroke, stroke, acute, vascular accident